ENCOD Press release 12. March 2026 VIENNA – International delegates taking part in the annual Commission ...
ENCOD is a pan-European organisation founded in 1993, working to reform global drug policy. It promotes human rights-based, public health-driven, and socially just approaches. Moreover, it challenges prohibition and supports fair, effective, and evidence-based alternatives across Europe and beyond.
Advocating and networking for evidence-based drug policy reform, human rights, public health, and harm reduction globally.
Promoting human rights, public health, harm reduction, and open evidence-based dialogue on drug policies internationally.
Supporting cooperation, transparency, evidence-based development, and dialogue between civil society organisations and policymakers.
ENCOD brings together experts, organisations, and advocates across key drug policy areas. By aligning knowledge, experience, and coordinated action, we strengthen harm reduction and advance evidence-based drug policy reform grounded in public health and human rights.
ENCOD works to advance drug policy reform by promoting fair, effective, and evidence-based approaches. We support policies grounded in human rights, public health, and social realities, encouraging dialogue, cooperation, and legislative change across national and international frameworks shaping drug policy.
ENCOD promotes harm reduction as a central pillar of drug policy, supporting measures that reduce health and social risks. We advocate evidence-based approaches, safer use practices, and inclusive policies that prioritise dignity, public health, and the real needs of affected communities.
Cannabinoids shape how cannabis works, from THC and CBD to CBG, CBN, and newer synthetic variants. ENCOD provides evidence-based insight into legal frameworks, supports informed public debate, and promotes responsible drug policy development.
Stimulants affect energy, focus, and alertness, from traditional plants like coca leaf and khat to cocaine and pharmaceutical substances. ENCOD addresses these drugs within political, legal, and harm-reduction debates shaping national and international drug policy.
Sedatives include poppy-derived opioids such as morphine, codeine, and heroin. ENCOD examines these substances through legal, regulatory, and public health perspectives, focusing on access, balanced regulation models, and long-term societal impact.
Psychedelics such as psilocybin, ayahuasca, ibogaine, entactogens, kambo, and delirants are addressed by ENCOD through political and legal frameworks, with a focus on cultural use, protecting indigenous rights, emerging research, and evolving regulatory models.
ENCOD’s campaigns bring together civil society, experts, and communities to drive change in drug policy. Through advocacy, awareness, and cooperation, we promote human rights, public health, and evidence-based approaches, turning shared knowledge into collective action across local, national, and international levels.
ENCOD unites a diverse network of activists, researchers, professionals, and community organisations from across Europe and beyond. Our members share experience, support one another, and work together to influence policy and protect rights.
Global initiative raising awareness on overdose prevention, remembering lives lost, and reducing stigma around drug-related harm.
Global campaign promoting harm reduction, drug policy reform, and health-centred approaches instead of punishment and criminalisation.
United Nations day raising awareness on drug use, prevention, and global drug policy challenges and responses.
Executive-level conference on cannabis markets, investment, regulation, and global industry trends across Europe.
Business-oriented cannabis expo covering supply chains, regulation, production, and European market development strategies.
Innovation-focused cannabis event exploring regulation, technology, and future policy frameworks across European markets.
Large international cannabis trade fair featuring exhibitors, education, innovation, and global cannabis community engagement.
Established cannabis expo focusing on CBD markets, regulation, innovation, and Swiss pilot program developments.
Focused event on medical cannabis access, regulation, and patient-centred policy development in Europe.
High-level policy and investment forum connecting regulators, healthcare leaders, and industry stakeholders across Europe.
Follow ENCOD’s blog featuring original articles, member contributions, and relevant international drug policy news. We share research and advocacy insights, helping readers stay informed, connected, and actively engaged in reform efforts worldwide.
ENCOD Press release 12. March 2026 VIENNA – International delegates taking part in the annual Commission ...
Press release Vienna, March 5th 2026 ENCOD at the #CND69 ENCOD’s delegation to CND6 ...
VIENNA – A new travelling exhibition comparing the divergent cannabis policies of France and the Netherlands ...